To amend title 18, United States Code, to limit the ability to assess a fee for health care services for prisoners, and for other purposes.
Summary
HR9525 is an early-stage bill referred to the House Judiciary Committee that would limit fees for health care services for prisoners. It has no text, no co-sponsors, and no funding appropriation. The legislative path is uncertain and near-term market impact is negligible.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9525 is a procedural bill with no market impact at this stage.
- 2.No tickers are affected; no causal chain can be drawn with confidence above 0.65.
- 3.The bill is unlikely to advance in the 119th Congress given a single non-voting sponsor and no committee momentum.
Market Implications
No near-term implications for healthcare equities ($UNH, $HCA, $JNJ, $MRK, $ABBV, $PFE, $LLY, $ABT, $MDT). Prison healthcare fee policy is a federal administrative matter that does not affect the revenue models of any publicly traded company. The bill would need to advance through the full legislative process and include funding mechanisms or mandatory changes for the private sector before any market signal emerges.
Full Analysis
HR9525 was introduced on 2026-06-29 by Del. Norton [D-DC] and referred to the House Committee on the Judiciary. The bill amends title 18 of the U.S. Code to limit the ability to assess fees for health care services for prisoners. However, the bill is in the earliest legislative stage — introduced and referred — with no committee hearing, markup, or vote scheduled. No companion bill has been introduced in the Senate. The sponsor is a non-voting Delegate, which reduces legislative momentum.
No funding is authorized or appropriated by this bill. The mechanism is a prohibition or cap on fee assessment, not a spending program. Therefore, there is no money trail for contractors or healthcare providers. The bill would affect federal prison healthcare administration, not private healthcare markets.
There are no related signals, procurements, or presidential actions in the provided context that converge with this bill. It is a standalone, narrow bill affecting a small federal population.
No publicly traded company is directly or indirectly impacted by this bill. Prison healthcare is primarily managed by federal employees (Bureau of Prisons) or a small number of private vendors; the bill does not mandate additional spending or change procurement for any publicly traded entity. Even the largest health insurers ($UNH) or hospital chains ($HCA) have negligible exposure to federal prison fee structures.
The bill has no timeline pressure. If it progresses, it would need a subcommittee hearing, full committee markup, House floor vote, Senate introduction and passage, and presidential signature — all unlikely in a single session for a single-sponsor, early-stage bill with no cosponsors or companion.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →